The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Christopher & Banks Corp

NYSE: CBK
Last

(U.S.) $5.53

Today's change0.00 0.00%
Updated March 27 4:03 PM EDT. Delayed by at least 15 minutes.
 

Christopher & Banks Corp

NYSE: CBK
Last

(U.S.) $5.53

Today's change0.00 0.00%
Updated March 27 4:03 PM EDT. Delayed by at least 15 minutes.

Christopher & Banks Corp closed at (U.S.)$5.53.

Over the last five days, shares have lost 4.49% and are down 3.15% for the last year to date. This security has underperformed the S&P 500 by 24.65% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $5.53
  • High--
  • Low--
  • Bid / Ask(U.S.) $5.18 / (U.S.) $5.95
  • YTD % change-3.15%
  • Volume0
  • Average volume (10-day)547,791
  • Average volume (1-month)324,681
  • Average volume (3-month)289,929
  • 52-week range(U.S.) $4.12 to (U.S.) $11.22
  • Beta1.95
  • Trailing P/E4.41×
  • P/E 1 year forward41.49×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.25
Updated March 27 4:03 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:Cyclical Consumer Goods & ServicesIndustry:Retail - Apparel & Accessories
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJan 31, 201501/31/2015Nov 01, 201411/01/2014Aug 02, 201408/02/2014May 03, 201405/03/2014
Revenue98111107103
Total other revenue--------
Total revenue98111107103
Gross profit29443838
Total cost of revenue69676965
Total operating expense104101103101
Selling / general / administrative31313132
Research & development--------
Depreciation / amortization3333
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income-6933
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-6933
Income after tax32933
Income tax, total-38000
Net income32933
Total adjustments to net income--000
Net income before extra. items32933
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items32933
Inc. avail. to common incl. extra. items32933
Diluted net income32933
Dilution adjustment--------
Diluted weighted average shares38383838
Diluted EPS excluding extraordinary itemsvalue per share0.860.240.090.07
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.860.240.090.07